NASDAQ:FTXH

First Trust Nasdaq Pharmaceuticals ETF (FTXH) Price, Holdings, & News

First Trust Nasdaq Pharmaceuticals ETF logo
$43.81 -0.42 (-0.95%)
Closing price 04:00 PM Eastern
Extended Trading
$43.17 -0.64 (-1.46%)
As of 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH)

Advanced

Key Stats

Today's Range
$43.70
▼
$44.62
50-Day Range
$40.43
▼
$44.86
52-Week Range
$31.36
▼
$45.10
Volume
57,593 shs
Average Volume
232,266 shs
Market Capitalization
$1.19 billion
Assets Under Management
$1.20 billion
Dividend Yield
0.66%
Net Expense Ratio
0.60%
Aggregate Rating
Moderate Buy

ETF Overview

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.

First Trust Nasdaq Pharmaceuticals ETF Expenses

TypeFTXHHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFs
Management Fee0.60%0.55%0.57%0.54%0.53%
Other Expenses0.00%0.52%0.53%0.38%0.54%
Total Expense0.60%0.76%0.75%0.69%0.73%
Fee Waiver0.00%-0.85%-0.67%-0.41%-0.67%
Net Expense0.60%0.58%0.63%0.61%0.60%
Receive FTXH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for First Trust Nasdaq Pharmaceuticals ETF and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

FTXH ETF News Headlines

My $247 scanner for $7
Bill Poulos is cutting the price of his $247 Instant Scanner to $7 for Black Friday. It's a one-time payment that covers a full year, with no subscription and no re-bills. Every night after the close, the scanner screens nearly a thousand of America's biggest stocks. It returns a short list of qualifying setups with the exact buy price next to each one. There's nothing to install. If you decide it's not for you, you get the $7 back and keep the scanner for the year.tc pixel
Surprising Analyst 12-Month Target For FTXH
See More Headlines

FTXH ETF - Frequently Asked Questions

First Trust Nasdaq Pharmaceuticals ETF's stock was trading at $32.9960 on January 1st, 2026. Since then, FTXH shares have increased by 32.8% and is now trading at $43.81.

First Trust Nasdaq Pharmaceuticals ETF's top institutional investors include First Trust Advisors LP (70.28%), Benjamin Edwards Inc. (0.61%), Oppenheimer & Co. Inc. (0.55%) and D.A. Davidson & CO. (0.34%).

Shares of FTXH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Fund Details

Issuer
First Trust
Fund Name
First Trust Nasdaq Pharmaceuticals ETF
Tax Classification
Regulated Investment Company
Stock Exchange
NASDAQ
Current Symbol
NASDAQ:FTXH
Inception Date
9/20/2016
Fund Manager
Daniel Lindquist, Jon Erickson, David McGarel, Roger Testin, Stan Ueland, Chris Peterson, Erik Russo
Web
N/A

Fund Focus

Asset Class
Equity
Benchmark
Nasdaq US Smart Pharmaceuticals Index
Category
Sector
Focus
Health Care
Development Level
Developed Markets
Region
North America
Number of Constituents
51

Fund Statistics

Assets Under Management
$1.20 billion
Average Daily Volume
$84.72 thousand
Discount/Premium
0.02%

Administrator, Advisor and Custodian

Administrator
The Bank of New York Mellon Corporation
Advisor
First Trust Advisors L.P.
Custodian
The Bank of New York Mellon Corporation
Distributor
First Trust Portfolios L.P.
Transfer Agent
The Bank of New York Mellon Corporation
Trustee
N/A
Lead Market Maker
Old Mission

Options

Optionable
N/A
Short Interest
91,009 shs

Miscellaneous

Beta
0.45
Creation Unit
50,000
Creation Fee
$500.00
Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

Top 10 FTXH Holdings

FTXH Sector Exposure

FTXH Industry Exposure


This page (NASDAQ:FTXH) was last updated on 11/16/2026 by MarketBeat.com Staff.
From Our Partners